IRIS
MINUTO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.675
AS - Asia 624
SA - Sud America 82
NA - Nord America 51
AF - Africa 15
Totale 19.447
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 18.659
SG - Singapore 267
CN - Cina 160
VN - Vietnam 146
BR - Brasile 51
US - Stati Uniti d'America 33
HK - Hong Kong 16
MX - Messico 15
AR - Argentina 13
ID - Indonesia 10
EC - Ecuador 9
IQ - Iraq 5
ZA - Sudafrica 4
CL - Cile 3
KE - Kenya 3
KZ - Kazakistan 3
RU - Federazione Russa 3
TN - Tunisia 3
VE - Venezuela 3
DO - Repubblica Dominicana 2
JP - Giappone 2
MY - Malesia 2
PE - Perù 2
SA - Arabia Saudita 2
SE - Svezia 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DE - Germania 1
EG - Egitto 1
GB - Regno Unito 1
IL - Israele 1
IN - India 1
JO - Giordania 1
MK - Macedonia 1
ML - Mali 1
NE - Niger 1
NG - Nigeria 1
NL - Olanda 1
OM - Oman 1
PK - Pakistan 1
PL - Polonia 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 19.447
Salva come PNG Salva come JPEG
Città #
Genova 12.220
Genoa 3.733
Rapallo 1.625
Vado Ligure 1.056
Singapore 105
Ho Chi Minh City 63
Beijing 58
Hanoi 27
Bordighera 20
Ashburn 17
Hong Kong 16
Haiphong 9
Tianjin 9
Mexico City 7
Da Nang 6
Guayaquil 6
São Paulo 5
Thái Bình 5
Biên Hòa 4
Bắc Ninh 3
Joinville 3
Nairobi 3
Ninh Bình 3
Orem 3
Rome 3
Campinas 2
Cape Town 2
Coro 2
Hải Dương 2
Jakarta 2
Johannesburg 2
Lima 2
Los Angeles 2
Phủ Lý 2
Ribeirão Preto 2
Surabaya 2
Tokyo 2
Tunis 2
Abidjan 1
Ambato 1
Amman 1
Aquidabã 1
Arica 1
Atlanta 1
Baghdad 1
Baku 1
Bamako 1
Barquisimeto 1
Benito Juarez 1
Benque Viejo el Carmen 1
Berezne 1
Brasília 1
Brooklyn 1
Béja 1
Bạc Liêu 1
Cabreúva 1
Cairo 1
Camaquã 1
Campo Limpo Paulista 1
Capitán Bermúdez 1
Carapicuíba 1
Cataguases 1
Chacabuco 1
Chandigarh 1
Changchun 1
Changsha 1
Chengdu 1
Cipó 1
Ciudad Victoria 1
Clorinda 1
Concordia 1
Curitiba 1
Formosa 1
Franca 1
Francisco Morato 1
Frankfurt am Main 1
García 1
Goiana 1
Greenville 1
Heemserveen 1
Heshan 1
Hillah 1
Hortolândia 1
Houston 1
Huế 1
Ibagué 1
Ihtiman 1
Itajaí 1
Itapipoca 1
Itatiba 1
Jaboatão dos Guararapes 1
Jeddah 1
Jinan 1
Johor Bahru 1
João Pessoa 1
Kharkiv 1
Khasavyurt 1
Krasnodar 1
Kuningan 1
Lagos 1
Totale 19.097
Salva come PNG Salva come JPEG
Nome #
Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre. 208
Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone (GH) replacement therapy in adults with GH deficiency. 207
SOMATOSTATIN AND DOPAMINE RECEPTOR INTERACTION IN PROSTATE AND LUNG CANCER CELL LINES 197
Diabetes secondary to neuroendocrine gastroenteropancreatic tumors 196
Effect of environment on growth: auxological and hormonal parameters in African and Italian children 194
Pituitary image: pituicytoma. 189
Acromegaly is associated with increased cancer risk: A survey in Italy 183
Absence of histological malignancy in a patient cohort with follicular lesions on fine-needle aspiration 180
Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system 180
Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients 179
Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease 176
Computed tomography colonography in acromegaly 176
Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and border-line value of the hormone 175
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology 174
A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma 173
Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases 171
Diagnostic value of the acid-labile subunit in Acromegaly: Evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3 170
Characterization of the IGF system in 15 patients with Alstrom syndrome. 170
Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease 169
Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study 169
Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas 167
Effects of the neuropeptide Y on estradiol and progesterone secretion by human granulosa cells in culture 167
Increasing hirsutism due to a granulosa-cell tumor in a woman with polycystic ovary syndrome: case report and review of the literature. 166
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth. 164
The pathology of the ulnar nerve in acromegaly. 163
Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience. 162
Circulating nitric oxide in women affected by weight loss amenorrhea during pulsatile gonadotropin-releasing hormone therapy 161
Rapid pituitary tumor shrinkage with dissociation between antiproliferative and antisecretory effects of a long-acting octreotide in an acromegalic patient 160
A unique association of clinical "persistent müllerian duct syndrome" and syringoid carcinoma of the perineal-scrotal skin: a consequence of urologic surgery? 159
Indirect evidence of hormone abuse. Proof of doping? 157
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogs and dopastatins 155
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 154
Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue. 154
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation 154
Effect of the acid-labile subunit on the binding of insulin-like growth factor (IGF)-binding protein-3 to [125I]IGF-I. J.Clin.Endocrinol.Metab. 80 (4):1318-1324, 1995. 153
Effect of the somatostatin analog, octreotide, and of other hormones on the release of the acid-labile subunit of the 150 kDa complex by rat hepatocyte in primary culture. 153
Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing 151
Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with turner's syndrome in culture 151
Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns? 150
Pancreatic Islet Cell Tumor Secreting Insulin-Like Growth Factor Type-II in a Dog. 150
Therapeutic Strategies and Clinical Outcome in Papillary Thyroid Microcarcinoma: A Multicenter Observational Study. 148
Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women 148
Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas 147
Growth hormone secretion in pubertal and adult subjects. 146
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities 145
Pituitary tumor disappearance in a patient with newly diagnosed acromegaly primarily treated with octreotide LAR 145
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 145
Somatostatin receptor scintigraphy in thoracic diseases 144
Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments 144
Insulin treatment enhances expression of IGF-I in sural nerves of diabetic patients. 144
Initial staging of lymphoma with octreotide and other receptor imaging agents. 143
Effects of growth hormone on leptin metabolism and energy expenditure in hemodialysis patients with protein-calorie malnutrition 143
Paraneoplastic hypoglycemia due to an insulin-like growth factor type-II secreting hepatocellular carcinoma in a dog. 142
STUDY OF BIOASSAYABLE SOMATOMEDIN ON RENAL ARTERY AND VEIN 142
Evidence for autocrine mitogenic stimulation by somatomedin- C/insulin-like growth factor I on an established human lung cancer cell line 142
Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells 140
Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population 138
Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. 138
Rationale and design of PATRO Adults, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope(R) for the treatment of adult patients with growth hormone deficiency 138
Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly 138
Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients 138
Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose. 136
Behaviour of typeII receptors of IGFs in different age and thyroid status in adult rat liver 135
Insulin-like growth factor I (IGF I) receptor autophosphorylation and kinase activity. Effect of a human polyclonal antibody (pIgG) 134
Treatment of a pituitary metastasis from a neuroendocrine tumour: case report and literature review. 134
Papillary thyroid cancer in a struma ovarii: a report of a rare case 134
Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis. 133
P68 Insulin-like growth factor (IGF) binding protein-3 inhibits IGF-II-stimulated IRS-1/PI-3-kinase activity and cell growth in human non-small cell lung cancer (NSCLC) cell lines 133
Evidence for an increased somatomedin-C/insulin-like growth factor I content in primary human lung tumors 133
Sympathovagal imbalance in acromegalic patients 132
Decreased serum somatomedin C concentrations during sleep: temporal relationship to the nocturnal surges of growth hormone and prolactin. 132
Interrelationships between follicle stimulating hormone and the growth hormone--insulin-like growth factor--IGF-binding proteins axes in human granulosa cells in culture 132
Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter. 130
Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cells in vitro. 130
Effects of microinflammation on growth hormone's sensitivity of potassium and amino acid metabolism in patients with chronic renal failure. 129
Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data. 129
Current diagnostic guidelines for biochemical diagnosis of acromegaly. 128
Ultrasound measurement of median and ulnar nerve cross-sectional area in acromegaly. 128
Trigger Finger, an Early Musculoskeletal Manifestation of Acromegaly 128
OR2,6 Interrelationship between somatostatin/dopamine pathways and growth factors in non-small lung cancer cells 126
P87 Effect of exenatide, sitagliptin and vildagliptin on IGF-I in diabetic patients 125
Effects of alpha-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro. 123
Sympathovagal imbalance in transsexual subjects. 122
Replacement therapy and cardiovascular diseases 122
Effect of octreotide on circulating IGF-I chromatographic profile: evidence for an inhibitory action on the formation of the 150-kDa ternary complex 122
Institutional experience of PTH evaluation on fine-needle washing after aspiration biopsy to locate hyperfunctioning parathyroid tissue. 121
Cost-of-illness study in acromegalic patients in Italy 121
Ten years of gastroeneteropancreatic neuroendocrine tumors: is reclassification Worth while? 121
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5 121
Pre-surgical treatment with somatostatin analogues in patients with acromegaly: The case for 120
Regulation Of Prostate Cancer Cell Proliferation By Somatostatin Receptor Activation 120
Increased insulin-like growth factor (IGF)-II and IGF/IGF-binding protein ratio in prepubertal constitutionally tall children 120
Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man. 119
Significant tumour shrinkage after 12 months of Lanreotide Autogel-120 mg treatment given first-line in acromegaly 119
Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy 119
Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency. 119
Potential indications for somatostatin analogues: immune system and lymphoproliferative disorders 118
The undescended testis. Prevalence and clinical features 116
Wireless connections in a hospital ward: the WARD-IN-HAND Project 115
Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: implications for the in vivo visualization during somatostatin receptor scintigraphy. 115
Totale 14.679
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.624
article - articoli 54.005
book - libri 0
conference - conferenze 2.507
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.112
Totale 115.248
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021618 0 0 0 0 0 74 62 108 93 116 77 88
2021/20221.863 35 97 168 233 72 128 134 434 89 174 58 241
2022/20231.937 177 143 37 227 310 351 3 130 303 5 226 25
2023/2024782 41 105 12 114 65 128 51 46 46 14 57 103
2024/20252.650 53 183 76 172 389 247 281 435 103 86 277 348
2025/20261.862 535 95 214 318 616 84 0 0 0 0 0 0
Totale 19.496